Mrv0541 02231216042D 18 18 0 0 1 0 999 V2000 3.1475 2.7532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.9760 1.9462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1913 1.6913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5783 2.2433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0198 0.8843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2352 0.6294 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.9803 -0.1553 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1553 -0.1553 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.3297 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1501 -0.7365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.6351 -1.4039 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0 -2.1200 -2.0713 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.3025 -0.9190 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -0.9676 -1.8888 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0997 0.6294 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.8843 0.8843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.5678 1.1143 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.5678 1.9393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 3 5 1 0 0 0 0 6 5 1 6 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 1 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 11 13 1 0 0 0 0 11 14 2 0 0 0 0 8 15 1 0 0 0 0 15 16 1 6 0 0 0 15 17 1 0 0 0 0 6 17 1 0 0 0 0 17 18 1 1 0 0 0 M CHG 2 12 -1 13 -1 M END > DB02236 > drugbank > NCC(=O)N[C@@H]1O[C@@H](COP([O-])([O-])=O)[C@H](O)[C@H]1O > InChI=1S/C7H15N2O8P/c8-1-4(10)9-7-6(12)5(11)3(17-7)2-16-18(13,14)15/h3,5-7,11-12H,1-2,8H2,(H,9,10)(H2,13,14,15)/p-2/t3-,5-,6+,7+/m0/s1 > InChIKey=OBQMLSFOUZUIOB-DOAVWBMOSA-L > 8 > 23.412346231089437 > 1 > 4 > 284.040951914 > -2 > C7H13N2O8P > 0 > [(2S,3R,4R,5R)-5-(2-aminoacetamido)-3,4-dihydroxyoxolan-2-yl]methyl phosphate > -2.48 > -4.650616976017662 > -0.78 > 284.1605 > 0 > 1 > -1 > 6.245768050847792 > 1.2255744528280514 > 8.141960108603826 > 177.23 > 53.051399999999994 > 5 > 1 > 5.33e+01 g/l > [(2S,3R,4R,5R)-5-(2-aminoacetamido)-3,4-dihydroxyoxolan-2-yl]methyl phosphate > 0 > DB02236 > experimental > Glycinamide Ribonucleotide $$$$